Boron neutron therapy can theoretically treat thymoma recurrence. The main focus of current research in boron neutron capture therapy is the treatment of patients with malignant brain tumors, recurrent head and neck tumors, and cutaneous melanomas. Although most patients with brain tumors and head and neck cancers are not cured, the available evidence supports that the therapy has some clinical efficacy.
Boron neutron capture therapy, or neutron therapy, destroys cancer cells through a nuclear reaction within the tumor cells. Neutron therapy begins by injecting the patient with a special boron-containing compound, which has a strong affinity for cancer cells when it enters the body, and will rapidly accumulate in cancer cells and rarely distribute in other tissues.
This kind of boron containing compound is harmless to human body, then irradiate the boron containing compound with neutron radiation, the ray is almost harmless to the body, but once it enters into the cancer cells, it will have a strong nuclear reaction with boron and release very fatal radiation, and the range of the radiation is very short, so it only kills the cancer cells and doesn’t damage the surrounding tissues.
It is recommended that patients with recurrent thymoma go to the hospital for treatment in time to reduce the adverse effects of the disease and improve the quality of life.